A few days ago, we said fear would lead to opportunity in quantum computing stocks.
All after some of the top quantum stocks took a dive on CEO Jensen Huang’s comments that “very useful” quantum computers are likely decades away. Then, Meta Platforms’ Mark Zuckerberg said quantum computing was years away.
“I’m not really an expert on quantum computing, but my understanding is that’s still quite a ways off from being a very useful paradigm,” the CEO said, as quoted by CNBC, adding that many people think the technology is likely a “decade plus out.”
But the markets shrugged it off.
Look at oversold shares of RGTI.
Even after a 48% move higher on Tuesday, it’s still technically oversold with big momentum ahead of it. It’s also over-extended on RSI, MACD and Williams’ %R. From its last traded price of $8.95, we’d like to see RGTI initially refill its bearish gap at around $20 a share.
Huge Alerts
Great news for investors—Zacks SCR has raised its price target for BSEM shares to $32.50! 📈
The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method. BioREtain® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure.
Even QBTS is a screaming buy, oversold at $4.73.
It’s also just as oversold on RSI, MACD and Williams’ %R and could soon refill its bearish gap at around $10 a share. All because most of the negativity surrounding CEO comments is greatly priced into both of these stocks.
